Skip to main content
Clinical Trials/NCT03667859
NCT03667859CompletedNot Applicable

Vaginal Elasticity Assessment Before and After Brachytherapy/Pelvic Radiation as Measured by Vaginal Tactile Imaging

Rambam Health Care Campus1 site in 1 country25 target enrollmentStarted: November 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
25
Locations
1
Primary Endpoint
Vaginal elasticity assessment

Study Overview

Brief Summary

Female patients with either uterine/cervical malignancies will be evaluated for vaginal elasticity using vaginal tactile imaging both before and after radiation treatment.

Detailed Description

Patients will be recruited and sign a consent form. The patients included are patients with either uterine/cervical malignancies. Each participant undergoes radiation treatment either as primary or complementary treatment.

Assessment of vaginal elasticity via vaginal tactile imaging will be performed at 3 different points:

  • Before the first treatment session (baseline).
  • After the last session of laser treatment.
  • 3 months post final treatment. Every patient will serve as her own control. Demographic, gynecologic and obstetric history will be obtained from patients' electronic files.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Any woman undergoing either brachytherapy or pelvic radiation treatment as primary or complementary treatment for a cervical/uterine malignancy.

Exclusion Criteria

  • Women that are not in the age range.
  • Women with massive vaginal bleeding.
  • Women after pelvic exenteration.

Outcomes

Primary Outcomes

Vaginal elasticity assessment

Time Frame: up to 6 months from enrollment

Vaginal elasticity as measured by the vaginal tactile imager.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

ROY LAUTERBACH MD

Principal Investigator

Rambam Health Care Campus

Study Sites (1)

Loading locations...

Similar Trials